Body Rejuvenation - Prolax
Producto de salud natural autorizado en Canadá
- Otros nombres
- Acidophilus Ultra DAILY CARE III
- Titular
- New Roots Herbal Inc.
- NPN o DIN-HM
- 80115009
- Estado
- Licencia activa
- Fecha de licencia
- 23 de diciembre de 2021
- Fecha de revisión
- No indicada
- Forma
- Kit
- Vía de administración
- Orale
- Tipo de solicitud
- Générale (non traditionelle)
Si este producto se vendiera en Francia
- Conditions légales
Frangula purshiana Cooper: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes ainsi qu'une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. Órdenes francesas de 9 de mayo de 2006 (nutrientes), 24 de junio de 2014 (plantas) y 26 de septiembre de 2016 (otras sustancias), fondo LEGI consolidado, consultado el 23 de octubre de 2026.
- Conditions légales
Rheum officinale Baill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. Órdenes francesas de 9 de mayo de 2006 (nutrientes), 24 de junio de 2014 (plantas) y 26 de septiembre de 2016 (otras sustancias), fondo LEGI consolidado, consultado el 23 de octubre de 2026.
Solo se calcula una cantidad diaria para una posología oral explícita para adultos, expresada por día y en una unidad sólida correspondiente a la forma del producto. No se extrapolan las unidades ambiguas, los líquidos, los polvos ni las dosis pediátricas. Una cantidad no calculada no se compara con los límites de dosis. Este análisis no constituye una autorización de venta en Francia ni una evaluación de seguridad o eficacia.
Composición
| Ingrediente medicinal y fuente | Por unidad posológica, según la fuente | Máximo diario, adulto |
|---|---|---|
| Bifidobacterium breve Fuente : UB8674 | 0,33 Milliards d'UFC | No calculada |
| Bifidobacterium breve Fuente : Bifidobacterium breve - Cellule entière | 0,33 Milliards d'UFC | No calculada |
| Plantago ovata Fuente : Enveloppe | 2.128 mg | No calculada |
| Bifidobacterium longum subsp. infantis Fuente : Bifidobacterium longum subsp. Infantis - Whole Cell | 0,33 Milliards d'UFC | No calculada |
| Bifidobacterium longum subsp. infantis Fuente : UB9214 | 0,33 Milliards d'UFC | No calculada |
| Enzymes pancréatiques Fuente : Sus scrofa - pancréas Potencia : 34.450 Unité d'activité protéase de la USP Protease | 325 mg | No calculada |
| Enzymes pancréatiques Fuente : Sus scrofa - pancréas Potencia : 7.832,5 Unité d'activité lipase de la USP Triacylglycerol lipase | No especificada | No calculada |
| Enzymes pancréatiques Fuente : Sus scrofa - pancréas Potencia : 37.350 unité d¿activité amylase de la USP alpha-Amylase | No especificada | No calculada |
| Lacticaseibacillus casei Fuente : UB1499 | 7,7473 Milliards d'UFC | No calculada |
| Chondrus crispus Fuente : En entier | 210 mg | No calculada |
| Capsicum annuum Fuente : Capsicum annuum - fruit | 20 mg | No calculada |
| Chondrus crispus | 20 mg | No calculada |
| Frangula purshiana Fuente : Frangula purshiana - Écorce âgée | 180 mg | No calculada |
| Juglans cinerea | 160 mg | No calculada |
| Rheum officinale Fuente : Rheum officinale - Racine et rhizome | 110 mg | No calculada |
| Zingiber officinale Fuente : Zingiber officinale - Rhizome | 20 mg | No calculada |
| Syzygium aromaticum | 53 mg | No calculada |
| Lacticaseibacillus rhamnosus Fuente : UB5115 | 7,7473 Milliards d'UFC | No calculada |
| Lactiplantibacillus plantarum Fuente : Lactiplantibacillus Plantarum - Cellule entière | 0,077 Milliards d'UFC | No calculada |
| Lactiplantibacillus plantarum Fuente : UB2783 | 0,077 Milliards d'UFC | No calculada |
| Lacticaseibacillus paracasei Fuente : UB1978 | 0,055 Milliards d'UFC | No calculada |
| Vitamine C Fuente : Acide ascorbique | 6 mg | No calculada |
| Morella cerifera Fuente : Écorce de racine | 70 mg | No calculada |
| Hibiscus sabdariffa Fuente : Fleur | 126 mg | No calculada |
Ingredientes no medicinales
Hypromellose, acide oléique, Trehalose, Feuille de stevia rebaudiana, Fécule de pommes de terre, Alginate de sodium, Phosphate dicalcique, Dioxyde de silice, Acide stéarique, Eau d'ammoniaque, Triglycérides à chaîne moyenne, Stéarate de magnésium, Eau purifiée, Extrait de soie de maïs, Croscarmellose de sodium, Xylooligosaccharides, Ethylcellulose
Dosis recomendadas en Canadá
| Población | Edad | Cantidad por toma | Frecuencia |
|---|---|---|---|
Adultos Traducido automáticamente del francés. Ver el originalAdultes | Traducción no disponible. Texto original, idioma: francés. minimum : 19 ans | No especificada Traducido automáticamente del francés. Ver el originalNon précisée | No especificada Traducido automáticamente del francés. Ver el originalNon précisée |
Usos autorizados en Canadá
Traducción no disponible. Texto original, idioma: inglés.
Acidophilus Ultra DAILY CARE III: Source of probiotics. Acidophilus Ultra DAILY CARE III: Helps support intestinal/gastrointestinal health. Acidophilus Ultra DAILY CARE III: Could promote a favorable gut flora. Prolax: Cascara sagrada is traditionally used in herbal medicine as a stimulant laxative for short term relief of occasional constipation. Prolax: Used in herbal medicine to promote bowel movement by direct action on the large intestine. Ultra Fibre Plantago: Psyllium is used in herbal medicine as a bulk-forming laxative and to promote bowel movements by increasing bulk volume and water content. Ultra Fibre Plantago: Psyllium provides gentle relief of constipation and/or irregularity. Rosemary and Clove are Traditionally used in Herbal Medicine as a carminative for the relief of digestive complaints such as flatulence, or abdominal distention. Pancreatin: Digestive aid. Pancreatin: Helps to decrease bloating after high caloric, high fat meals.Un uso autorizado en Canadá no es una declaración de propiedades saludables autorizada en la Unión Europea. Consulte el registro de declaraciones de propiedades saludables.
Advertencias en Canadá
Traducción no disponible. Texto original, idioma: inglés.
Cautions and Warnings : Do not follow this program during pregnancy or if you are breastfeeding or have any form of inflammatory bowel disease, such as, Crohn¿s disease, regional ileitis, or ulcerative colitis. Should you experience intense discomfort at any time, discontinue the program immediately. The Body Rejuvenation Kit is a nutritional supplement, not a replacement for proper medical attention. This program is not intended as a treatment for any disease or condition. Consult a licensed health care practitioner of your choice if you need direction on any health care problem.
For Prolax: Consult a health care practitioner if symptoms persist or worsen.
For Prolax: Consult a health care practitioner prior to use if you are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications, thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance.
For Prolax: Consult a health care practitioner prior to use if you have a kidney disorder, faecal impaction or symptoms such as abdominal pain, nausea, vomiting or fever.
For Prolax: Reduce dose or stop use if you experience abdominal pain, cramps, spasms and/or diarrhoea.
For Prolax: Call a Poison Control Center immediately if overdose or accidental ingestion occurs.
For Prolax: Keep out of the reach of children.
For Acidophilus: If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use.
For Acidophilus: Stop use and consult a health care practitioner if symptoms of digestive upset (e.g. diarrhea) occur, worsen and/or persists beyond 3 days.
For Ultra Fibre Plantago: Consult a health care practitioner if symptoms worsen of if laxative effect does not occur within 7 days.
For Ultra Fibre Plantago: Consult a health care practitioner if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking the product.
For Ultra Fibre Plantago: Consult a health care practitioner prior to use if you are taking medications which inhibit peristaltic movement (e.g. opoids, loperamide), or if you have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of abnormal constrictions of the gastrointestinal tract, disease of the esophagus and/or the superior opening of the stomach (cardia), potential or existing intestinal blockage, paralysis of the intestine, megacolon, faecal impaction, inflamed bowel or appendicitis).
For Ultra Fibre Plantago: Do not exceed the recommended dosage.
For Ultra Fibre Plantago: Consult a health care practitioner prior to use if liver function is impaired or if taking acetaminophen or anticoagulants.
For Ultra Fibre Plantago: Not for prolonged use in high doses except under supervision of a qualified health care practitioner.
For Ultra Fibre Plantago: Consult a health care practitioner prior to use if you have stomach ulcers or inflammation.
For Springlife: Stop use and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heartbeat and/or difficulty breathing.
For Springlife: If you have profuse mucous, consult a health care practitioner prior to use.
For Pancreatin: Consult a health care practitioner if symptoms persist or worsen.
For Pancreatin: Consult a health care practitioner prior to use if you are pregnant or breastfeeding.
For Pancreatin: Consult a health care practitioner prior to use if you have diabetes, pancreatitis, pancreatic exocrine insufficiency or cystic fibrosis.
For Pancreatin: Storage conditions: Store in a tightly closed, light-resistant container in a cool, dry place.Traducción no disponible. Texto original, idioma: inglés.
Contra-Indications : For Prolax: Do not use this product if you are pregnant or breastfeeding.
For Prolax: Do not use this product if you have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease such as Crohn's disease or ulcerative colitis, abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes or diarrhoea.
For Prolax: Do not use if you have hypokalemia, high blood pressure, or a kidney or cardiovascular disorder.
For Prolax: Do not use if you have arthritis.
For Prolax: Contraindicated in those with a weak stomach and those who do not have constipation.
For Acidophilus Ultra: Do not use this product if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
For Ultra Fibre Plantago: Do not use if you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or failure to defaecate following the use of another laxative product.
For Ultra Fibre Plantago: Do not use if you have diabetes mellitus in which blood sugars are difficult to regulate.
For Ultra Fibre Plantago: Do not use if you have difficulty swallowing.
For Ultra Fibre Plantago: Do not use if you are pregnant or breastfeeding or undergoing corticosteroid treatment.
For Ultra Fibre Plantago: Do not use if you suffer from febrile disorder.
For Ultra Fibre Plantago: Do not use this product if you are taking thiazide diuretics, cardiac glycosides, corticosteroids, stimulate laxatives or other medications which may aggravate electrolyte imbalance.
For Ultra Fibre Plantago: Do not use if you have diabetes, high blood pressure, hypokalemia, liver, heart or kidney disorders.
For Springlife: Do not take if you are pregnant or breastfeeding.
For Springlife: Do not take if you have been diagnosed with a liver disorder or if liver function is impaired; if you are taking acetaminophen or anticoagulants; if you have a fever and/or suffer from a febrile disorder.
For Springlife: If you have heart disease, high or low blood pressure, kidney or liver disorder, diabetes or edema (swelling of hands, face and feet) or are taking products containing diuretics, do not use.
For Pancreatin: Do not use if you are sensitive to pancreatic enzymes.
For Pancreatin: Do not use if you are sensitive to pork proteins.Traducción no disponible. Texto original, idioma: inglés.
Known Adverse Reactions : For Prolax: Stop use if hypersensitivity/allergy occurs.
For Prolax: With chronic use or abuse, disturbances of electrolyte balance, especially potassium deficiency, albuminuria and hematuria may occur; Rectal bleeding or failure to have a bowel movement after the use of a laxative may indicate a serious condition.
For Prolax: May cause cramp-like discomfort of the gastrointestinal tract, which may require a reduction of dosage.
For Prolax: The astringent effect of rhubarb may exacerbate, rather than relieve symptoms of constipation.
For Ultra Fibre Plantago: Hypersensitivity, such as allergy, has been known to occur following inhaled and/or ingested psyllium, in which case discontinue use.
For Ultra Fibre Plantago: May cause temporary gas and/or bloating.
For Ultra Fibre Plantago: Consult a health care practitioner in the event of an allergic reaction, nausea, vomiting, or diarrhea.
For Springlife: Large doses (many times the recommended dosage) of bayberry may be emetic and cause stomach problems.
For Pancreatin: Nausea, vomiting, abdominal pain/epigastric pain and/or heartburn have been known to occur, in which case discontinue use (and consult a health care practitioner).Fuente
Ficha oficial de Health Canada, licencia 80115009
Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias, consultado el 27 de octubre de 2026.
Contient des informations visées par la Licence du gouvernement ouvert – Canada (Santé Canada, BDPSNH)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
La fórmula vendida en Europa con el mismo nombre puede ser diferente. Esta información no sustituye el consejo de un médico o farmacéutico.
Se desconoce la fecha de la prueba de esta lista de ingredientes.
¿Ha cambiado el producto? Fotografíe el envase.